Synspira
Cambridge, US · Founded 2017 · Delaware LLC · 5 employees on LinkedIn
Founders & leadership
WP
William P. Wiesmann, M.D.Named on SEC filing
SB
Shenda BakerNamed on SEC filing
GB
Glenn BatchelderNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 1 round · 2017
▶$8.2MraisedSep 2017 · 4 investors · PharmaceuticalsRule 506(b)
▶$8.2MraisedSep 2017 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William P. Wiesmann, M.D.Director
- Shenda BakerExecutive Officer, Director
- Glenn BatchelderDirector
- Offering amount
- $8.2M
- Amount sold
- $8.2M
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Synspira raised?
- Synspira has disclosed $8.2M raised across 1 round.
- Where is Synspira headquartered?
- Synspira is headquartered in Cambridge, US.